PREEMIEr Diagnostics

Curated by Signal

Developer of a device to measure the blood glucose level in premature infants

Life Sciences Technologyprematurebabyhealth.com

Overview

Developer of a device to measure the blood glucose level in premature infants. The device will help in the identification of premature infants who need an adjustment to their glucose levels and identify the onset of disease.

Key facts

Founded: 2020
Headquarters: United States
Stage: Sign up to view
Industry: Life Sciences Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Accuray
Developer of AI-based robotic radiosurgery planning and delivery systems
Life Sciences TechnologySunnyvale, United States
Neurotron
Developing neuro electrodiagnostic devices
Life Sciences TechnologyTrenton, United States
Geneopedia
Developer of a bioinformatics platform for NGS
Life Sciences TechnologyRochester, United States

About PREEMIEr Diagnostics

What does PREEMIEr Diagnostics do?

Developer of a device to measure the blood glucose level in premature infants.

Where is PREEMIEr Diagnostics headquartered?

PREEMIEr Diagnostics is headquartered in United States.

When was PREEMIEr Diagnostics founded?

PREEMIEr Diagnostics was founded in 2020.

Which sector is PREEMIEr Diagnostics in?

PREEMIEr Diagnostics operates in Life Sciences Technology.

Who are PREEMIEr Diagnostics's competitors?

Companies similar to PREEMIEr Diagnostics include Accuray, Neurotron, and Geneopedia.